Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.
Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, Pisapia D, Vosoughi A, Fernandez E, Shohdy KS, Manohar J, Beg S, Wilkes D, Robinson BD, Khani F, Bareja R, Tagawa ST, Ouseph MM, Sboner A, Elemento O, Faltas BM, Mosquera JM. Ohara K, et al. Among authors: tagawa st. Nat Commun. 2024 Mar 18;15(1):2009. doi: 10.1038/s41467-024-46320-w. Nat Commun. 2024. PMID: 38499531 Free PMC article.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA. Beltran H, et al. Among authors: tagawa st. Cancer Discov. 2011 Nov;1(6):487-95. doi: 10.1158/2159-8290.CD-11-0130. Cancer Discov. 2011. PMID: 22389870 Free PMC article.
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Beltran H, Yelensky R, Frampton GM, Park K, Downing SR, MacDonald TY, Jarosz M, Lipson D, Tagawa ST, Nanus DM, Stephens PJ, Mosquera JM, Cronin MT, Rubin MA. Beltran H, et al. Among authors: tagawa st. Eur Urol. 2013 May;63(5):920-6. doi: 10.1016/j.eururo.2012.08.053. Epub 2012 Sep 5. Eur Urol. 2013. PMID: 22981675 Free PMC article.
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
Beltran H, Tagawa ST, Park K, MacDonald T, Milowsky MI, Mosquera JM, Rubin MA, Nanus DM. Beltran H, et al. Among authors: tagawa st. J Clin Oncol. 2012 Dec 20;30(36):e386-9. doi: 10.1200/JCO.2011.41.5166. Epub 2012 Nov 19. J Clin Oncol. 2012. PMID: 23169519 No abstract available.
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer.
Tagawa ST, Akhtar NH, Nikolopoulou A, Kaur G, Robinson B, Kahn R, Vallabhajosula S, Goldsmith SJ, Nanus DM, Bander NH. Tagawa ST, et al. Front Oncol. 2013 Aug 26;3:214. doi: 10.3389/fonc.2013.00214. eCollection 2013. Front Oncol. 2013. PMID: 23986881 Free PMC article.
Immunologics and chemotherapeutics for renal cell carcinoma.
Diamond E, Riches J, Faltas B, Tagawa ST, Nanus DM. Diamond E, et al. Among authors: tagawa st. Semin Intervent Radiol. 2014 Mar;31(1):91-7. doi: 10.1055/s-0033-1363848. Semin Intervent Radiol. 2014. PMID: 24596445 Free PMC article. Review.
Novel molecular targets for urothelial carcinoma.
Faltas BM, Karir BS, Tagawa ST, Rosenberg JE. Faltas BM, et al. Among authors: tagawa st. Expert Opin Ther Targets. 2015 Apr;19(4):515-25. doi: 10.1517/14728222.2014.987662. Epub 2015 Jan 30. Expert Opin Ther Targets. 2015. PMID: 25633079 Free PMC article. Review.
208 results